Ticker
SAGECompany Name
SAGE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 409.08M | 9.16 | $ 44.64M |
3/31/2025 | $ 454.48M | 9.13 | $ 49.78M |
12/31/2024 | $ 531.3M | 7.42 | $ 71.61M |
9/30/2024 | $ 604.99M | 10.02 | $ 60.41M |
6/30/2024 | $ 686.81M | 9.95 | $ 69.04M |
3/31/2024 | $ 755.44M | 12.22 | $ 61.8M |
12/31/2023 | $ 869.35M | 10.51 | $ 82.75M |
9/30/2023 | $ 933.27M | 7.02 | $ 133M |
6/30/2023 | $ 1.06B | 10.99 | $ 96.81M |
3/31/2023 | $ 1.2B | 14.21 | $ 84.69M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for SAGE THERAPEUTICS INC is calculated as follows: AssetsC [ $ 698.88M ] / LiabilitesC [ $ 59.66M ]
(=) Current Ratio [ 11.71 ]
Minimum
Sep 30, 2023
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.2K |
---|---|
min | 0 |
max | 6.79 |
average | 2.02 |
median | 1.62 |
std | 1.44 |